Expression of telomeric repeat binding factor-1 in astroglial brain tumors

Neurosurgery

Volumn 56, Issue 4, 2005, Pages 802-810

  La Torre, Domenico ^a   De Divitiis, Oreste ^a   Conti, Alfredo ^a   Angileri, Filippo Flavio ^a   Cardali, Salvatore ^a   Aguennouz, M'Hammed ^a   Aragona, Marcello ^a   Panetta, Stefania ^a   D'Avella, Domenico ^a   Vita, Giuseppe ^a   La Torre, Francesco ^a   Tomasello, Francesco ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Astroglial tumor; Brain tumor; Glioma; Telomere; Telomeric repeat binding factor

Indexed keywords

TELOMERIC REPEAT BINDING FACTOR 1;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN RADIATION; BRAIN TUMOR; CANCER GRADING; CLINICAL ARTICLE; CRANIOTOMY; ENZYME ACTIVITY; FEMALE; GLIOBLASTOMA; GLIOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROGLIA; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; TELOMERE; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ASTROCYTOMA; BRAIN NEOPLASMS; CRANIOTOMY; FEMALE; HUMANS; MALE; MICROSURGERY; MIDDLE AGED; TELOMERIC REPEAT BINDING PROTEIN 1;

EID: 20144388956     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000156468.41461.6F     Document Type: Article

References (54)

1. Ancelin K, Brunori M, Bauwens S, Koering CE, Brun C, Ricoul M, Pommier JP, Sabatier L, Gilson EA: Targeting assay to study the cis functions of human telomeric proteins: Evidence for an inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2. Mol Cell Biol 22:3474-3487, 2002.
2. Aragona M, Buda Ca, Panetta S, Morelli M, Giudice A, Campagna FI, Pontoriero A, Cascinu S, La Torre F: Immunohistochemical telomeric-repeat binding factor-1 expression in gastrointestinal tumors. Oncol Rep 7:987-990, 2000.
3. Aragona M, De Divitiis O, La Torre D, Panetta S, D'avella D, Pontoriero A, Morelli M, La Torre I, Tomasello F: Immunohistochemical TRF1 expression in human primary intracranial tumors. Anticancer Res 21:2135-2139, 2001.
4. Aragona M, Maisano R, Panetta S, Giudice A, La Torre F: Telomere length maintenance involvement in aging and cancerogenesis. Int J Oncol 17:981-989, 2000.
5. Bianchi A, Smith S, Chong L, Elias P, de Lange T: TRF1 is a dimer and bends telomeric DNA. EMBO J 16:1785-1794, 1997.
6. Bianchi A, Stansel RM, Fairall L, Griffith JD, Rhodes D, de Lange T: TRF1 binds a bipartite telomeric site with extreme spatial flexibility. EMBO J 18:5735-5744, 1999.
7. Blackburn EH: Structure and function of telomeres. Nature 350:569-573, 1991.
8. Blasco MA, Funk W, Villeponteau B, Greider CW: Functional characterization and developmental regulation of mouse telomerase RNA. Science 269:1267-1272, 1995.
9. Broccoli D, Smogorzewska A, Chong L, de Lange T: Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat Genet 17:231-235, 1997.
10. Chin L, Artandi SE, Shen Q, Tonn A, Lee SL, Gottlieb GJ, Greider CW, DePinho RA: p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97:527-538, 1999.
11. Chong L, van Steensel B, Broccoli D, Erdjument-Bromage H, Hanish J, Tempst P, de Lange T: A human telomeric protein. Science 270:1663-1667, 1995.
12. Cong Y-S, Wright WE, Shay JW: Human telomerase and its regulation. Microbiol Mol Biol Rev 66:407-425, 2002.
13. d'Adda di Fagagna F, Hande PM, Tong WM, Lansdorp PM, Wang ZQ, Jackson SP: Functions of poly(ADP-ribose) polymerase in controlling telomere length and chromosomal stability. Nat Gen 23:76-80, 1999.
14. de Divitiis O, La Torre D: Inverse correlation of TRF1 expression and cell proliferation in human primary intracranial tumors. J Neurosurg Sci 45:1-6, 2001.
15. de Lange T: Protection of mammalian telomeres. Oncogene 21:532-540, 2002.
16. Evans SK, Lundblad V: Positive and negative regulation of telomerase access to the telomere. J Cell Sci 113:3357-3364, 2000.
17. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW, Villeponteau B: The RNA component of human telomerase. Science 269:1236-1241, 1995.
18. Griffith J, Bianchi A, de Lange T: TRF1 promotes parallel pairing of telomeric tracts in vitro. J Mol Biol 278:79-88, 1998.
19. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, de Lange T: Mammalian telomeres end in a large duplex loop. Cell 97:503-514, 1999.
20. Harada K, Kurisu K, Tahara H, Tahara E, Ide T, Tahara E: Telomerase activity in primary and secondary glioblastoma multiforme as a novel molecular rumor marker. J Neurosurg 93:618-625, 2000.
21. Harley CB, Vaziri H, Counter C, Allsopp RC: The telomere hypothesis of cellular aging. Exp Gerontol 27:375-382, 1992.
22. Hiraga S, Ohnishi T, Izumoto S, Miyahara E, Kanemura Y, Matsumura H, Arita N: Telomerase activity and alterations in telomere length in human brain tumors. Cancer Res 58:2117-2125, 1998.
23. Kanauchi H, Nobuyuki W, Ginzinger DG, Yu M, Wong MG, Clark OH, Duh QY: Diagnostic and prognostic value of Fas and telomeric-repeat binding factor-1 genes in adrenal tumors. J Clin Endocrinol Metab 88:3690-3693, 2003.
24. Karlseder J, Smogorzewska A, de Lange T: Senescence induced by altered telomere state, not telomere loss. Science 295:2446-2449, 2002.
25. Klapper W, Krams M, Qian W, Janssen D, Parwaresch R: Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation. Br J Cancer 89:713-719, 2003.
26. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumor of the Central Nervous System. Berlin, Springer-Verlag, 1993, ed 2.
27. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-225, 2002.
28. Kleinschmidt-DeMasters BK, Hashizumi TL, Sze CI, Lillehei KO, Shroyer AL, Shroyer KR: Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling. J Clin Pathol 51:284-293, 1998.
29. Le S, Zhu JJ, Anthony DC, Greider CW, Black PMcL: Telomerase activity in human gliomas. Neurosurgery 42:1120-1124, 1998.
30. Lee MS, Blackburn EH: Sequence-specific DNA primer effects on telomerase polymerization activity. Mol Cell Biol 13:6586-6599, 1993.
31. Lingner J, Cech TR: Purification of telomerase from Euplotes aediculatus: Requirement of a primer 3′ overhang. Proc Natl Acad Sci U S A 93:10712-10717, 1996.
32. Maitra A, Yashima K, Rathi A, Timmons CF, Rogers BB, Shay JW, Gazdar AF: The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumours. Cancer 85:741-749, 1999.
33. Manuelidis L: Genomic stability and instability in different neuroepithelial tumors: A role for chromosome structure? J Neurooncol 18:225-239, 1994.
34. Matsutani N, Yokozaki H, Tahara E, Tahara H, Kuniyasu H, Haruma K, Chayama K, Yasui W, Tahara E: Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas. Int J Oncol 19:507-512, 2000.
35. Morii K, Tanaka R, Onda K, Tsumanuma I, Yoshimura J: Expression of telomerase RNA, telomerase activity, and telomere length in human gliomas. Biochem Biophys Res Commun 239:830-834, 1997.
36. Nakanishi K, Kawai T, Kumaki F, Hiroi S, Mukai M, Ikeda E, Koering CE, Gilson E: Expression of mRNAs for telomeric repeat binding factor (TRF)-1 and TRF2 in atypical adenomatous hyperplasia and adenocarcinoma of the lung. Clin Cancer Res 9:1105-1111, 2003.
37. Nürnberg P, Thiel G, Weber F, Epplen JT: Changes of telomere lengths in human intracranial tumors. Hum Genet 91:190-192, 1993.
38. Ohyashiki JH, Hayashi S, Yahata N, Iwama H, Ando K, Tauchi T, Ohyashiki K: Impaired telomere regulation mechanism by TRF1 (telomere-binding protein), but not TRF2 expression, in acute leukemia cells. Int J Oncol 18:593-598, 2001.
39. Pandita TK: ATM function and telomere stability. Oncogene 21:611-618, 2002.
40. Pennisi E: A possible new partner for telomerase. Science 282:1395-1397, 1999.
41. Sano T, Asai A, Mishima K, Fujimaki T, Kirino T: Telomerase activity in 144 brain tumours. Br J Cancer 77:1633-1637, 1998.
42. Shay JW, Pereira-Smith O, Wright WE: A role for both RB and p53 in the regulation of human senescence. Exp Cell Res 196:33-39, 1991.
43. Shore D: Telomeres: Unsticky ends. Science 281:818-819, 1998.
44. Smith S, Giriat I, Schmitt A, de Lange T: Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 282:1484-1487, 1998.
45. Smogorzewska A, van Steensel B, Bianchi A, Oelmann S, Schaefer MR, Schnapp G, de Lange T: Control of human telomere length by TRF1 and TRF2. Mol Cell Biol 20:1659-1668, 2000.
46. Takakura M, Kyo S, Sowa Y, Wang Z, Yatabe N, Maida Y, Tanaka M, Inoue M: Telomerase activation by histone deacetylase inhibitor in normal cells. Nucleic Acids Res 29:3006-3011, 2001.
47. van Steensel B, de Lange T: Control of telomere length by the human telomeric protein TRF1. Nature 385:740-743, 1997.
48. van Steensel B, Smogorzewska A, de Lange T: TRF2 protects human telomeres from end-to-end fusions. Cell 92:401-413, 1998.
49. Wang H, Blackburn EH: De novo telomere addition by Tetrahymena telomerase in vitro. EMBO J 16:866-879, 1997.
50. Weil RJ, Wu YY, Vortmeyer AO, Moon YW, Delgado RM, Fuller BG, Lonser RR, Remaley AT, Zhuang Z: Telomerase activity in microdissected human gliomas. Mod Pathol 12:41-46, 1999.
51. Wright WE, Shay JW: Time, telomeres and tumors: Is cellular senescence more than an anticancer mechanism? Trends Cell Biol 5:293-297, 1995.
52. Yajima T, Yagihashi A, Kameshima H, Kobayashi D, Hirata K, Watanabe N: Telomerase reverse transcriptase and telomeric-repeat binding factor protein 1 as regulators of telomerase activity in pancreatic cancer cells. Br J Cancer 85:752-757, 2001.
53. Yamada M, Tsuji N, Nakamura M, Moriai R, Kobayashi D, Yagihashi A, Watanabe N: Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancers. Anticancer Res 22:3303-3307, 2002.
54. Yokota T, Suda T, Igarasci M, Kuroiwa T, Waguri N, Kawai H, Mita Y, Aoyagi Y: Telomere length variation and maintenance in hepatocarcinogenesis. Cancer 98:110-118, 2003.